Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma

International Journal of Oncology

Volumn 38, Issue 4, 2011, Pages 1047-1057

  Alaiya, Ayodele A ^a   Al Mohanna, Mai ^a   Aslam, Muhammad ^a   Shinwari, Zakia ^a   Al Mansouri, Layla ^a   Al Rodayan, Maha ^a   Al Eid, Maha ^a   Ahmad, Irfan ^a   Hanash, Kamal ^a   Tulbah, Asma ^a   Mahfooz, Ali Bin ^a   Adra, Chaker ^a,b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Biomarkers; BPH; Gleason scores; Prostate cancer; Protein expression; Proteomics

Indexed keywords

ADENOSINE TRIPHOSPHATE SYNTHASE BETA CHAIN; ALBUMIN; APOLIPOPROTEIN A1; B TUBUIN BETA 2; BETA TUBULIN; CREATINE KINASE; CREATINE KINASE BETA CHAIN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 2; CYTOKERATIN 8; DESMIN; ENOYL COENZYME A HYDRATASE; FIBRINOGEN; FIBRINOGEN GAMMA; GLYCEROPHOSPHATE; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 71; LIPOCORTIN 4; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROHIBITIN; PROTEIN 14 3 3; PROTEIN DISULFIDE ISOMERASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TROPOMYOSIN; TRYPSIN INHIBITOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; ETHNIC DIFFERENCE; FUNCTIONAL PROTEOMICS; GLEASON SCORE; HUMAN; HUMAN TISSUE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SAUDI ARABIA; SWEDEN; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTEOME; SAUDI ARABIA; SIGNAL TRANSDUCTION; SWEDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 79952326406     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.937     Document Type: Article

References (31)

1. Ziada AM and Crawford ED: Advanced prostate cancer. Prostate Cancer Prostatic Dis 2: 21-26, 1999.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
3. Socialstyrelsen: Statistics - Health and Diseases Cancer Incidence in Sweden 2007, www.socialstyrelsen.se. Journal 2007.
4. Abdalla I, Ray P and Vijayakumar S: Race and serum prostate-specific antigen levels: current status and future directions. Semin Urol Oncol 16: 207-213, 1998. (Pubitemid 28553367)
5. Dorkin TJ and Neal DE: Basic science aspects of prostate cancer. Semin Cancer Biol 8: 21-27, 1997. (Pubitemid 27417426)
6. Greene KL, Albertsen PC, Babaian RJ, et al: Prostate specific antigen best practice statement: 2009 update. J Urol 182: 2232-2241, 2009.
7. Charrier JP, Tournel C, Michel S, Dalbon P and Jolivet M: Two-dimensional electrophoresis of prostate-specific antigen in sera of men with prostate cancer or benign prostate hyperplasia. Electrophoresis 20: 1075-1081, 1999. (Pubitemid 29222470)
8. Torti FM: Genitourinary system. Curr Opin Oncol 9: B75-B77, 1997.
9. Lalani EN, Stubbs A and Stamp GW: Prostate cancer; the interface between pathology and basic scientific research. Semin Cancer Biol 8: 53-59, 1997. (Pubitemid 27417430)
10. Alaiya A, Roblick U, Egevad L, et al: Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma. Anal Cell Pathol 21: 1-9, 2000. (Pubitemid 32158816)
11. Alaiya AA, Oppermann M, Langridge J, et al: Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry. Cell Mol Life Sci 58: 307-311, 2001. (Pubitemid 32217362)
12. Lexander H, Hellman U, Palmberg C, et al: Evaluation of two sample preparation methods for prostate proteome analysis. Proteomics 6: 3918-3925, 2006. (Pubitemid 44065169)
13. Lexander H, Palmberg C, Hellman U, et al: Correlation of protein expression, Gleason score and DNA ploidy in prostate cancer. Proteomics 6: 4370-4380, 2006.
14. Alaiya AA, Franzen B, Fujioka K, et al: Phenotypic analysis of ovarian carcinoma: polypeptide expression in benign, borderline and malignant tumors. Int J Cancer 73: 678-683, 1997. (Pubitemid 127483063)
15. Alaiya AA, Franzen B, Moberger B, Silfversward C, Linder S and Auer G: Two-dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity. Electrophoresis 20: 1039-1046, 1999. (Pubitemid 29222466)
16. Franzen B, Auer G, Alaiya AA, et al: Assessment of homogeneity in polypeptide expression in breast carcinomas shows widely variable expression in highly malignant tumors. Int J Cancer 69: 408-414, 1996. (Pubitemid 26384112)
17. Alaiya A, Al-Mohanna M and Linder S: Clinical cancer proteomics: promises and pitfalls. J Proteome Res 4: 1213-1222, 2005. (Pubitemid 41213336)
18. Alaiya AA, Franzen B, Hagman A, et al: Molecular classification of borderline ovarian tumors using hierarchical cluster analysis of protein expression profiles. Int J Cancer 98: 895-899, 2002. (Pubitemid 34286687)
19. Alaiya AA, Franzen B, Hagman A, et al: Classification of human ovarian tumors using multivariate data analysis of polypeptide expression patterns. Int J Cancer 86: 731-736, 2000. (Pubitemid 30249887)
20. Franzen B, Hirano T, Okuzawa K, et al: Sample preparation of human tumors prior to two-dimensional electrophoresis of proteins. Electrophoresis 16: 1087-1089, 1995.
21. Gleason DF and Mellinger GT: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111: 58-64, 1974.
22. Epstein JI: An update of the Gleason grading system. J Urol 183: 433-440, 2010.
23. Lexander H, Franzen B, Hirschberg D, et al: Differential protein expression in anatomical zones of the prostate. Proteomics 5: 2570-2576, 2005. (Pubitemid 40966484)
24. Lexander H, Palmberg C, Auer G, et al: Proteomic analysis of protein expression in prostate cancer. Anal Quant Cytol Histol 27: 263-272, 2005. (Pubitemid 41504427)
25. KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J Natl Cancer Inst 90: 1284-1291, 1998. (Pubitemid 28433473)
26. Gannon PO, Koumakpayi IH, Le Page C, Karakiewicz PI, Mes-Masson AM and Saad F: Ebp1 expression in benign and malignant prostate. Cancer Cell Int 8: 18, 2008.
27. Liu AY, Zhang H, Sorensen CM and Diamond DL: Analysis of prostate cancer by proteomics using tissue specimens. J Urol 173: 73-78, 2005. (Pubitemid 39627676)
28. Epstein JI: What's new in prostate cancer disease assessment in 2006? Curr Opin Urol 16: 146-151, 2006.
29. Epstein JI, Allsbrook WC Jr, Amin MB and Egevad LL: Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists. Adv Anat Pathol 13: 57-59, 2006. (Pubitemid 44357147)
30. Sakr WA and Grignon DJ: Prostate. Practice parameters, pathologic staging, and handling radical prostatectomy specimens. Urol Clin North Am 26: 453-463, 1999.
31. Globocan-2002: The Globocan 2002 database at http://www-dep. iarc.fr/globocan/database.htm. 2002.